Both medications embody a novel class of antibody therapies designed to neutralize the SARS-CoV-2 agent. First, sotrovimab, created by Vir Biotechnology , demonstrated substantial effectiveness against https://gregorygrqs669571.aboutyoublog.com/53768131/sotrovimab-vir-7831-a-deep-investigation-into-the-antibody-treatment